¾i½Þ¹ê¥ÎÀç¾iÁ¿®y(2)¢w

·L¶qÄqª«½è²{¤µ¦p¦ó¡H~§Aªº¥À½Þ¨S¦³³h¦å¶Ü¡H~

³h¦å¹ïÁc´Þ¦¨ÁZªº¼vÅT

        ³h¦å®É¤§°ÝÃDÂI¡A¤HÃþ¤w¸Ô¥[¬ã¨s¡Cµo¨|¤¤¤§ªì¤¤¡B°ª¤¤¥Í¡A¹ð¨£¥þ¨­­Â«å¡BªÓ»Äµh¡B¯t·w¡B¤W½Ò¤¤¥´½OºÎµ¥¸û»´¤§¯gª¬¡A¤£¹L¦b¥¥°ü«h§e²{¸û¤j¤§°ÝÃD¡C

        ¥H¤U¬°¿ï¦ÛÂåÀø±MªùÂø»xClinician¤§"ÅK¯Ê¥F¯g¤§¯fºA»PªvÀø"¤§°O¨Æ¥[¥H¤¶²Ð¡C

³h¦å¹ï¥¥°ü¡B­L¨à¤§¼vÅT

        ¤Â¥¼¡GÅK¯Ê¥F©Ê³h¦å®É¡A¹ï¥¥°ü¤Î­L¨à§e¦p¦ó¤§¼vÅT¡H

        ¹a¤ì¡G¦¹°ÝÃD±q¥H«e§Y¦³¤£¦P»¡ªk¡A¦ý·|³y¦¨»P¤À®Y¡A¥Í²£¤§ª½±µÃö«Yªº¦³°}µh·L®z¡B¦¢½w¥X¦å¡A¥Bªc¨Å¤£¨¬¡A¤l®c«ì´_¤£¨Î¡A©ö©ó¤Þ°_¥Í²£·P¬Vµ¥°ÝÃD¡C³Ìªñ³Ì¯}Ãöª`ªº¬°­L¨àµo¨|»P³h¦å¤§°ÝÃD¡C

        ¨ä¤¤°}µh·L®z¤§¶µ¥Ø¡A±N"¤À®Y®É¶¡©µªø"¤§²{¶H¡A´«­Ó¤è¦VÆ[¤§¡A¦b½Þ¤è­±¡A¥H¤U¤§³ø§i¨Ò¤]»P³h¦å¦³±K¤Á¤§Ãö«Y¡C

        ·ç¨å¤§¬ã¨sªÌ³ø§iÅã¥Ü¡A§³®W´Á¤§¤j³¡¤À®É¶¡¡AÃö¤J¯UÄ椧¥À½Þ¡A156­L¤§¥­§¡¤À®Y®É¶¡¬°6.5¤p®É¡C¥t¤è­±¡A¦b¶}©ñ½ÞªÙ¸s¹}¤§¥À½Þ¡A265­L¤§¥­§¡¤À®Y®É¶¡¬°4.2¤p®É¡A¹}¾i©ó¯UÄ椧¥À½Þ¦h¥X50¢H¤§®É¶¡¡C¤S¡A¦]¤À®Y®É¶¡©µªø¡A­P¨Ï¦º²£¥J½Þ»Pµê®z¥J½Þ¼Æ¼W¥[¡B°O¿ý¨C­L¦s¬¡¥J½Þ¼Æ´î¤Ö0.5ÀY¡C¤À®Y¤¤¦º¤`¤§¥J½Þ¡A¤j³¡¤À¬°¤À®Y²×¤F®É©Ò¥Í²£¤§¥J½Þ¡A¦¹ºØ²{¶H¡A¯S§O¬O¤À®Y®É¶¡¶W¹L4¤p®É¥H¤W±¡ªpªÌ¦hµo¡C(¨ú¦Û¾i½Þ¤§¤Í1987¦~2¤ë¸¹)

        ³Ìªñ¥À½Þ¤§Å髬¥ç²`ªø¡A¥ç§Y¥H¤l®cªøªº½Þ¡A²£¥J¼Æ¦h¤§²z¥Ñ¨ü¨ì³ß¦n¡C¥H©¹¥À½Þ¤§¤l®cªø«×¡A¤@°¼¬°90¤½¤À¡A³Ìªñ¤§¥À½Þ¹F¨ì100¤½¤ÀªÌ¥ç¬Û·í¦h¡A¦¹¹ï¥Í²£¥J½Þ¼Æ¤§¼W¥[¨ã¦³¶µÄm¡C¥t¤è­±¡Aµo¨|¨}¦n­L¨à(¦b¤l®c³Ì²`³BªÌ)¤§¦º²£¡A¨Æ¹ê¤W¬O¦b¥Í²£ª½«e©|¦s¬¡¡A¦Ó«á¦º²£ªÌ¡C

        ¨Ì½Õ¬dÆ[¤§¡A­L¨à¦b¥À½ÞÅ餺¡AÂÀ±a¤ÁÂ_¦Ü¥Í¥XÅé¥~¡A¦p®É¶¡¶W¹L¤G¤ÀÄÁ®É¡A«h±N³y¦¨®ñ®ð¤£¨¬°²¦º©Î²¿®§¦º¤`¡C¦¹¤]¬O»P¤À®Y©µªø¤Æ¦³Ãö¤§¨Æ¡A¬Æ¦Ü¤]¥i»¡¬O»P³h¦å¦³Ãö¡C

        «e­z¤§³h¦å¹ï§³°ü¡B­L¨à¤§¼vÅT¤¤¡u¨Å¥Ä¤Àªc¤£¨¬¡v¬O¥H¡u¨Åªc¥X¤£¨Î¡v¡B¡u¤l®c«ì´_¤£¨Î¡v¬O¥H¡u¤À®Y«á¤l®c¦¬ÁY¤£¨}¡B¦Aµo¨|¤£¨Î¡v¡B¡u©ö©ó¤Þ°_¥Í²£·P¬V¡v¬O¥H¡u©ö¤Þ°_²£¿È¼ö¡v¡B¡u­L¨à¤§µo¨|»P³h¦å¡v¬O¥H¡u¥Í²£¥XÅé­«¤p¡AµL¦å¦â¤Î¬¡¤O¤£¨Î¤§¥J½Þ¡vµ¥¡C¥iµø¬°³h¦å¥À½Þ©öµo¥Íªº°ÝÃD¡C³o¨Ç³£»PÅK¤í¯Ê¤Î³h¦å¦³²`¤Á¤§Ãö«Y¡C

        ¥À½Þ³h¦å¤§¹ê»Ú±¡ªp¡A¥Ñ©ó²£¦¸¤§¼W¥[¡A¥À½Þ¦å¬õ¯À¶q¦³­°§C¶É¦V¡A¤w©ó«e¤¶²Ð¹L¡A¦ý³o¨Ç¥þ¬O¥Ñ©ó«e­z¤§³h¦å©Ò¦ñÀHµo¥Í¤§¯e¯f»P°ÝÃD¤§­ì¦]¡C¥i»¡¬°¦­´Á²^¨O¤§¥D­n¦]¯À¡C

        ¥À½Þ³h¦å¤§§ïµ½¡GÅK¦bÅ餺µLªk¦X¦¨¡A¦]¦¹¬°¤F§ïµ½¥À½Þ¤§ÅK¯Ê¥F©Ê³h¦å¡AµL½×¦p¦ó¡A¥²»Ý¥Ñ¥~³¡¸É¥R¦h¶q¤§ÅK¤À¡C¬G¦b¦¹±N¦UºØÅK¾¯¤§¯S¼x¥[¥H¾ã²z»¡©ú¡C

        ¤@¡B²¸»Ä²Ä¤@ÅK

        ¦¹¬°°µ¬°¹}®Æ²K¥[ª«¡A¦b¤é±`¤¤¼s¬°À³¥Î¤§·G»ù¤§µL¾÷ÅK¡C¦ý³q±`¤§µ¹¤©¶q¬°»s³y¦å¬õ¯À©Ò¥²»Ý¤§ÅK¤À(ferritin)¦b¥À½Þ¨xŦµLªk¥R¤À¶JÂáA¦b¤À®Y®É©¹©¹³y¦¨¦å¬õ¯À¶q¤£¨¬¡C¥ç¦³³ø§iÅã¥Ü¶JÂÃÅK«ü¼Ð¤§¥À½Þ¦å²Mferritin¶q¡A©ó¤À®Y4¶g«e»PÂ÷¨Å®É¤§´ú©wµ²ªG¡AÂ÷¨Å®É­°§C¦Ü¤À®Y«e¤§41¢H¡C

        ¥t¥~¡A²¸»Ä²Ä¤@ÅKµ¥ªºµL¾÷ÅK­Y²K¥[¹L¦hªº¸Ü¡A·|§Î¦¨ÅKÂ÷¤l(¶§©Ê)¦b­G©Î¸zºÞ¤¤´åÂ÷¡A¥B¦]©ö©ó»P±a­t¹q(³±©Ê)ªº­G¤Î¸zÂH½¤µ²¦X¦Ó¶Ë®`ÂH½¤¡A¨äµ²ªG§ó·|¤Þµo­¹¼¤¤£®¶¡B³à¥¢Åé¤O¤Î¤Uµgµ¥¯f¯g¡C

        ¤G¡BDextranÅK

        ¦³¨Ç¬O­÷¨Å½Þ¥H¸g¤f¾¯¨Ï¥Î¡AdextranÅK¤§¤j³¡¤À§@¬°ª`®g¾¯¡A¥Î©ó­÷¨Å¤¤¤§¥J½Þ¡C¦¹ºØª`®g¥ÎdextranÅK¡A¦òù¨½¹F¤j¾ÇªºC.A.Ducsay¤óµ¥¨Ï¥Î©ó¥À½Þ¤§³ø§i¤º®e¤¶²Ð¦p¤U(ªí1)¡C

ªí1. ¥À½Þª`®gdextranÅK¹ï­L¨à¡B­L½L¤Î§¿½¤²G¤¤ÅK¶q¤§¼vÅT

1. ¸ÕÅç³õ©Ò

    ¦òù¨½¹F¤j¾Ç

    C.A.Ducsay, W.C.Buhi, F.W.Bazer, 1984

2. ¸ÕÅç¤èªk

    ¸ÕÅ碹

°Ï                 ¤À ÀY¼Æ dextranÅKª`®g(22mg¡þkg)­pµe
¡@ ¡@ °tºØ 40¤é¥Ø 45 50 55 60 90
¸ÕÅç°Ï 4ÀY ÅKª`®g ¡ô ¡ô ¡ô ¡ô ¡ô ¡@
¹ï·Ó°Ï 4ÀY µL

3. µ²ªG                                                                                                                                                                         

¡@ ¸ÕÅç°Ï ¹ï·Ó°Ï
(­L¨à¨xÂÃ) ¡@ ¡@
°®Àê¨xÂä¤ÅK¶q(mg¡þg) 1.2 1.3
Á`ÅK¶q(mg) 3.5 3.7
(­L½L) ¡@ ¡@
°®Àê­L½L¤¤ÅK¶q(mg¡þg) 0.4 0.4
Á`ÅK¶q(mg) 5.2 6.0

        ¨ä¤èªk¬°¦b§³®W40¡B45¡B50¡B55¡B60¤éÄÖµ¥5¦¸¡A¨C¤½¤çÅé­«ª`®gdextranÅK22²@§J¡C¹ï·Ó°Ï¬°¤@¯ë¤§ºÞ²z¡C©ó§³®W90¤éÄÖ±N¤l®c¤Á°£¡A¨ú¥X­L¨à´ú©w¨xÂäέL½L¤¤¤§ÅKÁ`¶q¡C±oª¾¥À½Þª`®gdextranÅK¡A¦b­L¨à¤§§l¦¬¤Î²¾¦æ©Ê§¡¤£°ª¡C

        ¤T¡BÐ`úd³J¥ÕÅK(Peptide)

        Ð`úd³J¥ÕÅK(Peptide)¬O¥Ñ¤G­Ó¥H¤WªºÓi°ò»Äµ²¦X¦¨Ð`úd«á¦A»PÅKÂ÷¤l¿ùµ²¦X¦Ó¦¨ªº¤@ºØÅK¾¯¡Aªñ¦~¨Ó³Q®Ö­ã©Ó»{¬°¹}®Æ²K¥[ª«¤§·sªºÅK¾¯¡C¦b­G»P¸zºÞ¤¤´X¥G¤£·|´åÂ÷¡A¨äºc³y¤D¬°®e©ö§l¦¬¤§ª«½è¡C¥À½Þ¤§µ¹¤©¨Ò©óªí2¤Îªí3¤¶²Ð¡C

ªí2. ¥À½Þ¦å²Mferritin¿@«×¤§¤ñ¸û(mg¡þml)

¡@ ÀY¼Æ ¸ÕÅç¶}©l®É

(¤À®Y28¤é«e)

¤À®Y®É Â÷¨Å®É

(28¤éÄÖ)

PeptideÅK°Ï 4 ¡@ 16.5±10.4 11.5±8.3
©µ­J¯Á»Ä²Ä¤@ÅK°Ï 4 ¡@ 4.5±3.7 5.3±4.7

ªí3. ¥À½Þ¦å¬õ¯À¶q¤§±À²¾        

¡@ ÀY¼Æ ¸ÕÅç¶}©l®É

(¤À®Y28¤é«e)

¤À®Y®É
PeptideÅK°Ï 8 12.9(100) 12.0(93.2)
²¸»Ä²Ä¤@ÅK°Ï 8 12.3(100) 10.6(86.2)

        ªí2¬°¥HÐ`úd³J¥ÕÅK¤Î©µ­J¯Á»Ä²Ä¤@ÅK·í§@ÅK¾¯¦b¥À½Þ¤À®Y4¶g«e¦Ü1¶g«e¨CÀY¨C¤éµ¹¤©600²@§J¡A¤Î¹w©w¤À®Y¤@¶g«e¦ÜÂ÷¨Å¤é(28¤éÄÖ)¨CÀY¨C¤éµ¹¤©¬ù1,200²@§J¡A¤§«á¤ñ¸ûÅ餺¶JÂä§ÅK¶q»P¦å²Mferritin¤§¶q¡C

        Â÷¨Å®É¨â°Ï¤§¦å²Mferritin(¶JÂÃÅK)¶q»P¸ÕÅç¶}©l®É¤ñ¸û¡APeptideÅK°Ï¬°88¢H¡A¦Ó©µ­J¯Á»Ä²Ä¤@ÅK¤j´T´î¤Ö¬°73¢H¡C

        ªí3¬°¤À®Y4¶g«e¦ÜÂ÷¨Å(28¤éÄÖ)¡A¥À½Þ¹}®Æ¤¤¤À§O¥HÐ`úd³J¥ÕÅK(Peptide)¤Î²¸»Ä²Ä¤@ÅK°µ¬°ÅK¾¯²K¥[125ppm¡A¤ñ¸û¥À½Þ¦å¬õ¯À¶q¡C

        ¤À®Y®É¨â°Ï¦å¬õ¯À¶q»P¸ÕÅç¶}©l®É¤ñ¸û¡AÐ`úd³J¥ÕÅK(Peptide)°Ï¬ù­°7¢H¡A¦Ó²¸»Ä²Ä¤@ÅK24¢H¡C¦ñÀH¥À½ÞÁc´Þ¦¨ÁZ¤§´£°ª»P¹}¾iÀô¹Ò¤§ÅܤơA¦å²G©Êª¬§e·L§®¤§ÅܤơC

        ¥À½ÞÀqÀq¤¤ªí²{¤F«e­z¤§¥Í²zªº¦MÀI«H¸¹¡AÂǥѺغتºÀˬd»PÆ[¹î¦­´Áµoı¡A¹Ï¿Ñ¥Í²£©Ê§ïµ½¤§¹ïµ¦¡C

        (¸Î¤¸¤½¥q¸ê®Æ´£¨Ñ¡A«ÝÄò)

¹}®ÆÀç¾iÂø»x(p.73~77)¡Ð³\®¶©¾¡D¤E¤@¦~²Ä¤Q¤G´Á

Copyright © 1998 ­Z¸s®n¯bªªºô. ¥»ºô¯¸¹Ï¤å«YÄÝ­Z¸s®n¦³­­¤½¥q¡A¤º¤å¤§ª©Åv¬°¸ÓÂø»xªÀ©Ò
¦³¡A«D¸g¥»¤½¥q¤Î¸ÓÂø»xªÀ¥¿¦¡®Ñ­±¦P·N¡A¤£±o±N¥þ³¡©Î³¡¤À¤º®e¡A
Âà¸ü©ó¥ô¦ó§Î¦¡´CÅé   ¡° ³Ì¨Î¸ÑªR«× 800x600
Copyright © 1998 MiobufferCo., Ltd.  All rights reserved.
Unauthorized copying and reproduction is prohibited. All trademarks property of their respective holders.